Gray Fleming - 30 Nov 2023 Form 4 Insider Report for BioSig Technologies, Inc. (BSGM)

Role
Chief Commercial Officer
Signature
/s/ Gray Fleming
Issuer symbol
BSGM
Transactions as of
30 Nov 2023
Net transactions value
$0
Form type
4
Filing time
04 Dec 2023, 19:01:39 UTC
Previous filing
09 May 2023
SEC
View on sec.gov
This filing has been restated, see here for the amended filing

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSGM Stock Option (Right to Buy) Award $0 +131,900 $0.000000 131,900 30 Nov 2023 Common Stock 131,900 $0.2603 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option fully vested on November 30, 2023, the date of grant, subject to the terms and conditions of the BioSig Technologies, Inc. 2023 Long-Term Incentive Plan and the stock option agreement by and between the Company and the reporting person.